We screened nearly 1 million patients/visitors entering our medical center for COVID-19 symptoms or exposures. After the first wave, very few (< 0.1%) failed screening regardless of community COVID-19 incidence @rickmartinello@YaleMed@JAMAInternalMed
Hospital entrance screening of patients and visitors for #COVID19 signs, symptoms, and exposures at 2 campuses of an academic medical center had limited benefit, as <0.1% of nearly 1 million visitors had a failed screening. https://t.co/yBhrpGXIFW
Screening lung donors for Ureaplasma and treating early can mitigate fatal hyperammonemia syndrome. @i_am_jlum and I review new findings from @BuzoBruno@wsligl and highlight the many unanswered questions @TheTxIDjournal
Whole genome sequencing confirmed a SARS-CoV-2 outbreak on our transplant unit. Watch for atypical presenting symptoms and test early & often! @TheTxIDjournal @CarloPalacios12 @maricar_malinis
1/2 November 2021 @AST_info@AST_IDCOP Article of the Month - Impact of Screening and Treatment ofย Ureaplasmaย species on Hyperammonemia Syndrome in Lung Transplant Recipients: A Single Center Experience https://t.co/0nKYoIkTKv